Index by author
Agnew, Kaylan
- Open AccessAn NGO-Implemented Community–Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern IndiaSujatha Sankaran, Prema S Ravi, Yichen Ethel Wu, Sharan Shanabogue, Sangeetha Ashok, Kaylan Agnew, Margaret C Fang, Raman A Khanna, Madhavi Dandu and James D HarrisonGlobal Health: Science and Practice December 2017, 5(4):668-677; https://doi.org/10.9745/GHSP-D-17-00192
Paid community health workers screened for hypertension in the community, referred cases to the clinic for diagnosis and initial treatment by a physician, and then monitored patients who had well-controlled blood pressure including dispensing maintenance medications prescribed by the physician. Blood pressure control was successful in the majority of such patients.
Ali, Moazzam
- Open AccessExtended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product LabelingMoazzam Ali, Luis Bahamondes and Sihem Bent LandoulsiGlobal Health: Science and Practice December 2017, 5(4):534-539; https://doi.org/10.9745/GHSP-D-17-00296
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
Ameh, Charles
- Open AccessAuthors' Response to Editorial: Maternal Death Surveillance and Response: A Tall Order for Effectiveness in Resource-Poor SettingsHelen Smith, Charles Ameh, Pamela Godia, Judith Maua, Kigen Bartilol, Patrick Amoth, Matthews Mathai and Nynke van den BroekGlobal Health: Science and Practice December 2017, 5(4):697-698; https://doi.org/10.9745/GHSP-D-17-00407
Amoth, Patrick
- Open AccessAuthors' Response to Editorial: Maternal Death Surveillance and Response: A Tall Order for Effectiveness in Resource-Poor SettingsHelen Smith, Charles Ameh, Pamela Godia, Judith Maua, Kigen Bartilol, Patrick Amoth, Matthews Mathai and Nynke van den BroekGlobal Health: Science and Practice December 2017, 5(4):697-698; https://doi.org/10.9745/GHSP-D-17-00407
Andersen, Kathryn
- Open AccessWhat Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan AfricaJanie Benson, Kathryn Andersen, Joan Healy and Dalia BrahmiGlobal Health: Science and Practice December 2017, 5(4):644-657; https://doi.org/10.9745/GHSP-D-17-00085
Across the 10 countries, 77% of 921,918 women left with a contraceptive method after receiving abortion care. While contraceptive uptake was high among all age groups, adolescents ages 15–19 were less likely to choose a method than women 25 years or older.
Ashok, Sangeetha
- Open AccessAn NGO-Implemented Community–Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern IndiaSujatha Sankaran, Prema S Ravi, Yichen Ethel Wu, Sharan Shanabogue, Sangeetha Ashok, Kaylan Agnew, Margaret C Fang, Raman A Khanna, Madhavi Dandu and James D HarrisonGlobal Health: Science and Practice December 2017, 5(4):668-677; https://doi.org/10.9745/GHSP-D-17-00192
Paid community health workers screened for hypertension in the community, referred cases to the clinic for diagnosis and initial treatment by a physician, and then monitored patients who had well-controlled blood pressure including dispensing maintenance medications prescribed by the physician. Blood pressure control was successful in the majority of such patients.
Askew, Ian
- Open AccessHarmonizing Methods for Estimating the Impact of Contraceptive Use on Unintended Pregnancy, Abortion, and Maternal HealthIan Askew, Michelle Weinberger, Aisha Dasgupta, Jacqueline Darroch, Ellen Smith, John Stover and Melanie YahnerGlobal Health: Science and Practice December 2017, 5(4):658-667; https://doi.org/10.9745/GHSP-D-17-00121
Five models estimate the impact of family planning on health outcomes, but the estimates previously have diverged because the models used different assumptions, inputs, and algorithms. After a collective harmonization process, the models now produce more similar estimates although they retain some minimal differences. These models assist in planning, resource allocation, and evaluation.
Asnake, Mengistu
- Open AccessImproving Contraceptive Access, Use, and Method Mix by Task Sharing Implanon Insertion to Frontline Health Workers: The Experience of the Integrated Family Health Program in EthiopiaYewondwossen Tilahun, Candace Lew, Bekele Belayihun, Kidest Lulu Hagos and Mengistu AsnakeGlobal Health: Science and Practice December 2017, 5(4):592-602; https://doi.org/10.9745/GHSP-D-17-00215
Between 2009 and 2015, 1.2 million women received Implanon implants from trained Health Extension Workers. Of the approximately 7,000 implant service visits made during the first 6 months, 25% were among women who had never used contraception before.
Asturias, Edwin J
- Open AccessHigh Background Congenital Microcephaly in Rural Guatemala: Implications for Neonatal Congenital Zika Virus Infection ScreeningAnne-Marie Rick, Gretchen Domek, Maureen Cunningham, Daniel Olson, Molly M Lamb, Andrea Jimenez-Zambrano, Gretchen Heinrichs, Stephen Berman and Edwin J AsturiasGlobal Health: Science and Practice December 2017, 5(4):686-696; https://doi.org/10.9745/GHSP-D-17-00116
A variety of microcephaly case definitions detect high background prevalence in rural Guatemala, which complicates congenital Zika screening efforts. In addition, gestational age is needed for most screening tools but is usually unknown in low-resource settings. Fenton growth curves, originally designed for use in preterm infants, offer a standardized approach to adjust for unknown gestational age and may improve screening efforts.
Bahamondes, Luis
- Open AccessExtended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product LabelingMoazzam Ali, Luis Bahamondes and Sihem Bent LandoulsiGlobal Health: Science and Practice December 2017, 5(4):534-539; https://doi.org/10.9745/GHSP-D-17-00296
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
In this issue
